MARKERS OF CHRONIC SYSTEMIC INFLAMMATION IN PATIENTS WITH ISCHEMIC HEART DISEASE IN COMBINATION WITH AUTOIMMUNE THYROIDITIS INFLUENCED BY RESVERATROL


  • Y. Ghalwash Ukrainian medical stomatological academy, Ukraine
  • N. Chekalina Ukrainian medical stomatological academy, Ukraine
  • Yu. Kazakov Ukrainian medical stomatological academy, Ukraine

Abstract

MARKERS OF CHRONIC SYSTEMIC INFLAMMATION IN PATIENTS WITH ISCHEMIC HEART DISEASE IN COMBINATION WITH AUTOIMMUNE THYROIDITIS INFLUENCED BY RESVERATROL

References

1. Shi, A., Tao, Z., Wei, P.&Zhao, J.,2016. Epidemiological aspects of heart.Exp Ther Meddiseases.12(3), pp. 1645–1650.

2. Vanderpump, M.P.J., 2011.The epidemiology of thyroid disease. BrMedBull. 99(1), pp. 39-51.

3. Pujara, K., Gunarathne, A.& Gershlick A.H.,2015. Inflammation is associated with myocardial ischemia. BrJCardiol. 22, pp. 101-104.

4. Koc, A., Batar, B., Celik, O., Onaran, I., Tasan, E. & Sultuybek, G.K., 2014. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population. Immunobiology. 219,7, pp. 531-536.

5. Galenko-Iaroshevsky, P.A., Sukoyan, G.V., Ionov, D. I., ZelenskayaA.V. &KhvitiaN.G., 2017. Possibility of inhibition of TNF-α/NF-kB signaling pathway activation in myocardium and reverse cardiac hemodynamics in chronic ischemic heart disease. J Clin Exp Pathol. 7(3)DOI: 10.4172/2161-0681.1000310.

6. Inoue, H. &Nakata,R., 2015.Resveratrol targets in inflammation. EndocrMetabImmuneDisordDrugTargets. 15(3), pp. 186-195.

7. Kutsenko, N.L., Savchenko, L.G., Kaydasheva, E.I., Kutsenko, L.A., Solochina, I.L. & Kaydashev, I.P., 2011. Determination of circulating CD32+ CD40+-microparticles — modification of degradation assessment of endothelial cells.Clinical Laboratory Dіagnostics. 7, pp. 20-23.

8. Nolan, T., Hands, R.E., & Bustin, S.A., 2006. Quantification of mRNA using real-time RT-PCR. Nature Protocols. 1, pp. 1559–1582.
Published
2019-11-07
How to Cite
Ghalwash, Y., Chekalina, N., & Kazakov, Y. (2019). MARKERS OF CHRONIC SYSTEMIC INFLAMMATION IN PATIENTS WITH ISCHEMIC HEART DISEASE IN COMBINATION WITH AUTOIMMUNE THYROIDITIS INFLUENCED BY RESVERATROL. Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 3(1), 39-40. https://doi.org/10.29256/v.03.01.2019.escbm23
Section
Selected abstracts